Our consumer healthcare products
We invest in building brands that consumers trust and come back to, time and time again.
Our Consumer Healthcare business develops and markets consumer preferred and expert recommended brands in the Oral health, Pain relief, Respiratory, Nutrition/gastro-intestinal and Skin health categories.
We are one of the world’s leading over-the-counter healthcare companies. We hold number one positions in Wellness across 36 markets and are market leaders in pain relief and specialist oral care.
We have a portfolio of loved and trusted brands that are underpinned by science including: Sensodyne, Polident, Voltaren, Panadol and Otrivin.
On 1 August 2019, we announced that we’d completed our transaction with Pfizer to combine our consumer healthcare businesses into a new world-leading Consumer Healthcare Joint Venture. The Joint Venture combines our portfolio of brands with Pfizer Consumer Healthcare brands, which include Advil, Centrum and Caltrate.
Within three years of the closing of the transaction, we intend to separate the Joint Venture via a demerger. With our future intention to separate, the transaction also presents a clear pathway forward for us to create a new global Pharmaceuticals/Vaccines company, and a new world-leading Consumer Healthcare company. Visit our consumer healthcare joint venture to find out more.
Today, people are taking an increasingly active role in managing their own health. This is being fuelled by an emerging global middle class, rising healthcare costs and ageing populations. Demand for consumer healthcare products is growing, particularly in emerging markets where consumers are seeking more affordable and accessible products.
Our strategy is to meet the everyday healthcare needs of our consumers through building consumer preferred and expert recommended brands.
To do this we focus on excellence in innovation to develop world class brands, and on building our reputation through best in class interactions with retailers, healthcare professionals and shoppers.
Research for product innovation
Our business is built on science and this research heritage contributes to the development of our Consumer Healthcare products, giving us a unique advantage over our competition.
Today, we are using science to speed up the time to develop new product innovations, make them more accessible to the people who need them, and to develop benefits our consumers value, ultimately growing our business.
At the same time, we continue to ensure we meet all regulatory requirements for testing, approval, manufacturing, labelling and marketing of our products.
You can find out more about our R&D work on Consumer Healthcare products in our Research section.
If you have a product idea and believe we might like to partner with you, please visit our Consumer Healthcare External Innovation portal.
The following list includes our major consumer products in New Zealand.
|Product (CMI PDF)||Consumer Website|
|Flixonase (PDF - 79.9 KB)||Flixonase.co.nz|
|Habitrol (PDF - 181 KB)|
|Panadol (PDF - 48 KB)||Panadol.co.nz|
|Panadol Osteo (PDF - 34.4 KB)||Panadol.co.nz|
|Robitussin (PDF - 243 KB)|
|Voltaren (PDF - 214 KB)||Voltaren.co.nz|
|Zovirax (PDF - 38.1 KB)||Zovirax.co.nz|
|Zyrtec (PDF - 75.7 KB)|